Search results
-
Dr Julian Sale
... to monitor the molecular choreography of proteins and DNA at sites of stalled replication. ...
-
Professor Duncan Jodrell
I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel therapeutic combinations, including first into man (phase I) and associated studies. My research goal is to identify...
-
Dr K Gatley
... 170 patients being recruited from UK participating sites. ...
-
Professor Ming-Qing Du
... B or T lymphocytes and occur at both nodal and extranodal sites. The accurate diagnosis of various lymphoma subtypes is critical in ...
-
Dr Richard Baird
Early phase clinical trials, including expertise in: ...
-
Miss Rachel Matthews
... to extract a small number of cells from multiple tumour sites; this sampling method provides a better capture of the cell populations ...
-
Dr Daniel Hodson
... cells or memory B cells, whereas less competitive B cells default to apoptosis. Rapidly changing, but tightly controlled, programmes of ...
-
Professor Jean Abraham
-
-
Dr Oscar M Rueda
Development of statistical methods and models for the analysis and integration of breast cancer high-throughput data: detection of alterations in DNA copy number and their influence in mRNA expression and survival, in order to obtain predictive markers....
-
Dr Robin Hesketh
I am based in the Biochemistry Department and work on several cancer related projects, primarily in collaboration with Jim Metcalfe, Kevin Brindle and Doug Easton. These fall into four areas (1) Development of anti-angiogenic gene therapy, (2) Studies...
-
Dr Anna-Maria Shiarli
-
Dr Avgi Andreou
-
Miss Anita Balakrishnan
-
Miss Alicia Garcia Gimenez
-
Mr Ashley Grimmer
-
Dr Andrew Baker
-
Miss Annie Howitt
-
Mr Ahmed Mohammed
-
Dr Alexander Fulton
-
Ms Alison Hallett
-
Dr Ali Amin Al Olama
... research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate Cancer Associated Alterations ...
-
Professor Antonis Antoniou
... of risk prediction models for familial breast, ovarian, prostate and other cancers with a familial component; - the identification and ...
-
Dr Alison Dunning
... international consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, ...
-
Dr Antony Rix
... announced a substantial investment led by XTX Ventures and Prostate Cancer Research - for more details see https://lucidamedical.com/2021-cambridge-ai-startup-prostate-cancer-investment/ ...
-
Dr Claire Crafter
My main focus is on understanding the mechanism of action of a range of agents targetting the PI3 Kinase pathway, particularly the AKT inhibitor AZD5363 and the mTORC1/2 inhibitor, AZD2014. I also have a stong interest in combination screening and...
-
Ms Ceilidh Welsh
... recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...
-
Dr Danish Mazhar
... awarded a PhD by Imperial College London for his research in Prostate Cancer. He has also previously received the McElwain Prize from the ... is the Principal Investigator of numerous clinical trials in Prostate, Bladder and Testis Cancers. He is a member of National Cancer ...
-
Mr David Thurtle
... laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer ...
-
Professor Douglas Easton
... to cancer, with particular emphasis on breast and prostate cancer. I also have particular interests in the genetic epidemiology ... conducting association studies in breast (BCAC) and prostate cancer (PRACTICAL), and in BRCA1/2 carriers. ...
-
Professor David Neal
... in CRI with interest in androgen receptor signalling in prostate cancer. We are studying androgen regulated genes as mediators of ... experimental medicine approaches in patients with high risk prostate cancer. I am also PI on a collaborative study of sequencing for human ...
-
Dr Andreas Bender
... large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I ...
-
Dr Alejandra Bruna
... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...
-
Dr Catherine Lindon
... to coordinated cell division, and have well documented cancer-promoting activities. Ongoing projects in the lab explore how ... in time and space, and how their activity contributes to cancer. We have recently described a 'ubiquitome' of cellular components ...
-
Dr Ashray Gunjur
... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...
-
Dr Ahsan MEMON
... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...
-
Dr Aisling Redmond
... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...
-
Professor Alan Warren
... how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome, containing ... it is also important for oncogenesis: a novel class of human cancer predisposition disorder has recently emerged that is caused by mutations ...
-
Professor Vincent Gnanapragasam
Vincent J Gnanapragasam holds a personal Chair in Urology at the University of Cambridge and is an Honorary Consultant Urologist at Addenbrooke’s Hospital, Cambridge. He graduated from Newcastle University and following basic surgical training, was...